Clinical Trial Update: Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating TP-102 bacteriophage therapy for diabetic foot ulcers, including infections with Pseudomonas aeruginosa, Staphylococcus au…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• TP-102 (bacteriophage therapy)

Snippet

Sponsor: Technophage, SA | Conditions: Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection | Phase 1, Phase 2 | Status: COMPLETED